Why Are My Triglycerides High With Diabetes — And What Actually Lowers Them?
It is the one number on your lipid profile that tends to move when you do — which is both the reason it is high and the reason it can come down.

Of the four numbers on a lipid profile, triglycerides are the one most likely to be flagged in a person with diabetes — and the one most likely to be quietly ignored, because attention goes to LDL and to whether a statin is needed. That is a missed opportunity, because triglycerides behave differently from LDL. LDL is stubborn and mostly answers to medication. Triglycerides answer to you.
They are also extremely common here. A five-year analysis of 552,719 lipid profiles from laboratories across all four provinces of Pakistan (opens in a new tab), published in the Journal of Clinical Lipidology in 2025, found that 53.7% — roughly one sample in two — had triglycerides of 150 mg/dL or above. That is the general testing population, not just people with diabetes. Among 509 patients at a diabetes clinic at Jinnah Postgraduate Medical Centre in Karachi (opens in a new tab), 74% of those with an HbA1c above 7% had high triglycerides. If your report came back flagged, you are in ordinary company.
Why diabetes pushes this number up in particular
Insulin does more than move glucose. It also switches off fat release from your fat tissue and switches on the enzyme that clears triglyceride-rich particles out of your bloodstream. When insulin is scarce or not working well, both of those jobs suffer at once: fat tissue keeps releasing free fatty acids into circulation, and the clearing enzyme is suppressed, so what is already there lingers.
Meanwhile the liver is doing the opposite of resting. The NIH's Endotext review of dyslipidaemia in diabetes (opens in a new tab) describes how high circulating insulin keeps switching on the liver's fat-manufacturing machinery even while the liver ignores insulin's signal to stop releasing glucose. The result is a liver making more triglycerides out of surplus, and a bloodstream slower at clearing them. Supply up, drainage down.
This is why the triglyceride line on your report is partly a glucose report. The Karachi study found HbA1c and triglycerides moved together with statistical significance — a modest but real correlation. If your triglycerides jumped since the last profile, your glucose logs are a reasonable first place to look, before your diet.
How high is high
Most Pakistani lab reports print a single cutoff at 150 mg/dL, which tells you whether you are over the line but not how far. The Endocrine Society's clinical practice guideline on hypertriglyceridaemia (opens in a new tab) uses bands, and the bands matter because the concern changes as you go up.
| Fasting triglycerides | Category | What this generally means |
|---|---|---|
| Below 150 mg/dL | Normal | No triglyceride-specific action needed. |
| 150–199 mg/dL | Mild | Lifestyle and glucose control; part of the usual diabetes risk picture. |
| 200–999 mg/dL | Moderate | Lifestyle and glucose control, plus a look for secondary causes. Cardiovascular risk is the main concern here. |
| 1000–1999 mg/dL | Severe | Treated as a risk for pancreatitis. Needs medical attention, not a wait-and-see. |
| 2000 mg/dL or above | Very severe | Same, more urgently. |
The severe bands are genuinely uncommon — the Pakistani laboratory analysis found severe hypertriglyceridaemia in about 1 person in 286, and very severe in about 1 in 861. But they exist, and they were more frequent in men and in the 36-to-45 age group. Most people reading this will be somewhere in the 150–500 range, where the risk being managed is to the heart and arteries over years, not to the pancreas this week.
Above roughly 1000 mg/dL, the Endocrine Society guideline treats hypertriglyceridaemia as a pancreatitis risk in its own right — a sudden, severe complication that has nothing to do with your heart risk score. If your report shows a number in the thousands, take it to a doctor promptly rather than filing it until your next appointment, even if you feel completely well.
The causes that are not your diet
Before rearranging your meals, it is worth ruling out the things a blood test and a medicine list can find. The ADA's Standards of Care (opens in a new tab) recommend that for anyone with triglycerides above 150 mg/dL fasting (or above 175 non-fasting), doctors treat secondary factors and avoid medications that raise triglycerides — not just counsel on lifestyle. The Endocrine Society makes the same point: elevated triglycerides should prompt a look for secondary causes, including endocrine conditions and drugs.
In practice that means an untreated thyroid problem, kidney disease, or a medicine you are taking for something else can be doing part of the work. This is a specific question worth asking at your next visit — "could anything on my list be raising this?" — rather than assuming the number is a verdict on how you have been eating.
What actually brings it down
There is an order to this, and it is not the order most people use. Glucose control comes first, because it is upstream of everything else: the Endotext review notes that poor glycaemic control raises triglycerides and lowers HDL together, and that improving control can markedly lower triglycerides. If your HbA1c is well above target, the triglyceride number will likely follow it down without any separate project.
The second point is that triglycerides respond to different food than LDL does. Advice aimed at LDL concentrates on saturated fat; triglycerides are far more sensitive to sugar and refined carbohydrate, because that surplus is exactly what the liver converts into fat. Liquid sugar is the sharpest version of this — sugary drinks, ganne ka ras, sweetened lassi and juice deliver a load with none of the fibre or bulk that slows it down. If you are going to change one thing for triglycerides specifically, that is usually the one with the most to give.
Weight loss and regular walking work here too, and they work through the same door — less surplus for the liver to convert, better insulin sensitivity to help clear what is made. None of this is different from what helps your blood sugar, which is the useful part: one set of habits, two numbers.
When medicine gets added
A statin is not a triglyceride drug. It is prescribed for LDL and for cardiovascular risk, and while it lowers triglycerides somewhat, it is not the tool anyone reaches for when triglycerides are the problem. Confusing the two is common and leads to the reasonable-sounding but wrong conclusion that because you are on a statin, your triglycerides are handled.
Where triglycerides are high enough to threaten the pancreas, the Endocrine Society names a fibrate as the first-line agent — fenofibrate lowered triglycerides by 29% in the FIELD trial. Separately, for people already on a statin with LDL under control but triglycerides still in the 150–499 range and cardiovascular risk present, the ADA says adding icosapent ethyl, a prescription high-dose purified EPA, can be considered; in the REDUCE-IT trial it produced a 25% relative reduction in major cardiovascular events. Which of these applies, if either, depends on where your number sits and what else is on your risk picture — it is a conversation with your physician, not a decision to make from a lab report.
Then measure it again
Triglycerides are volatile — more so than LDL — which cuts both ways. A single high reading after a heavy week is not a diagnosis, and a single good reading is not proof you have solved anything. What tells you something is the direction across three or four profiles, read next to the HbA1c values from the same months.
Log each lipid profile in Diatic alongside your HbA1c, so when your triglycerides drop you can see what dropped with them — and when they climb, you have somewhere to look.
Frequently asked questions
My triglycerides are high but my LDL and total cholesterol are normal. Is that still a problem?
Yes, and it is the most typical pattern in Type 2 diabetes — high triglycerides with a low HDL and an LDL that looks unremarkable. A normal-looking LDL does not cancel out a high triglyceride level; the ADA gives hypertriglyceridaemia its own recommendation precisely because it needs addressing on its own terms.
The blood was drawn without fasting. Does that make the triglyceride number unusable?
Not unusable, but read against a different line. The Endocrine Society advises that a diagnosis of hypertriglyceridaemia be based on fasting levels, and the ADA uses a higher threshold for non-fasting samples — above 175 mg/dL rather than above 150. If your result was borderline and you had eaten, repeating it fasting before drawing conclusions is reasonable.
Will fish oil capsules from the pharmacy do what the prescription does?
Not at the doses in ordinary supplements. In the ORIGIN trial, low-dose EPA plus DHA lowered triglycerides by about 14.5 mg/dL — a real but small effect. The prescription products studied for cardiovascular benefit used several grams a day of purified EPA and lowered triglycerides by roughly 18%. If your doctor wants that effect, they will prescribe it rather than suggest a supplement.
Sources
- American Diabetes Association (ADA) — Standards of Care in Diabetes 2025, Section 10: Cardiovascular Disease and Risk Management (opens in a new tab)
- Endotext (NCBI Bookshelf, NIH) — Dyslipidemia in Patients with Diabetes (opens in a new tab)
- MedlinePlus (U.S. National Library of Medicine) — Cholesterol testing and results (opens in a new tab)
- Pakistan Journal of Medical Sciences — Frequency and pattern of dyslipidemia and its association with other risk factors among Type-2 Diabetics (opens in a new tab)
- Cholesterol Treatment Trialists' (CTT) Collaboration — Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia: an individual participant data meta-analysis (The Lancet Diabetes & Endocrinology, 2024) (opens in a new tab)
- NHS (UK) — Statins (opens in a new tab)
- SAMSON trial — N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects (New England Journal of Medicine, 2020) (opens in a new tab)
- MedlinePlus (U.S. National Library of Medicine) — Atorvastatin (opens in a new tab)
- MedlinePlus (U.S. National Library of Medicine) — Simvastatin (opens in a new tab)
- StatPearls (NCBI Bookshelf, NIH) — Dietary Therapy for LDL Cholesterol Reduction: Evidence-Based Patterns for Cardiovascular Risk Management (opens in a new tab)
- StatPearls (NCBI Bookshelf, NIH) — Statin Medications (opens in a new tab)
- Jovanovski et al. — Effect of psyllium (Plantago ovata) fiber on LDL cholesterol and alternative lipid targets, non-HDL cholesterol and apolipoprotein B: a systematic review and meta-analysis of randomized controlled trials (The American Journal of Clinical Nutrition, 2018) (opens in a new tab)
- The Endocrine Society — Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline (Journal of Clinical Endocrinology & Metabolism, 2012) (opens in a new tab)
- Journal of Clinical Lipidology (2025) — Trends and prevalence of severe hypertriglyceridemia in Pakistan: A 5-year analysis (2019–2023) (opens in a new tab)
- Cureus (2017) — Correlation between Glycated Hemoglobin and Triglyceride Level in Type 2 Diabetes Mellitus (opens in a new tab)
- American Diabetes Association (ADA) — Standards of Care in Diabetes 2026, Section 10: Cardiovascular Disease and Risk Management (opens in a new tab)
- Drug Design, Development and Therapy (2019) — Pharmacokinetics of fixed-dose combination of atorvastatin and metformin compared with individual tablets (opens in a new tab)
- Diabetes & Metabolism Journal — Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial (opens in a new tab)
- American Diabetes Association (ADA) — Standards of Care in Diabetes 2026, Section 3: Prevention or Delay of Diabetes and Associated Comorbidities (opens in a new tab)
- Pan African Medical Journal (2013) — Prevalence of Vitamin B12 deficiency in patients of type 2 diabetes mellitus on metformin: a case control study from Pakistan (opens in a new tab)
- MedlinePlus (U.S. National Library of Medicine) — Metformin (opens in a new tab)
- NHS (UK) — Metformin (opens in a new tab)
- World Journal of Diabetes — Metformin-associated lactic acidosis: A mini review of pathophysiology, diagnosis and management in critically ill patients (opens in a new tab)
Related reading

Cholesterol Levels for a Diabetic Patient: What the Numbers Mean
Your lipid profile has four numbers on it, and diabetes changes them in a specific, predictable way — here is how to read yours.

Your LDL Is Above Target: What Actually Brings It Down
Knowing the number to aim for is the easy half — this is the honest ranking of what moves LDL, and by how much.

Diabetes and Fatty Liver Disease: The Silent Connection Explained
How extra glucose is converted into stored fat inside your liver, why early fatty liver causes zero pain, and practical lifestyle habits to clear liver fat naturally.

What Is Insulin Resistance? The 'Rusty Key' Explanation
Learn why your cells stop listening to insulin, why your pancreas works overtime in response, and how you can naturally improve insulin sensitivity.